American Heart Journal
Volume 146, Issue 2 , Pages 215-217 , August 2003

Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements

  • Hector O Ventura, MD

      Affiliations

    • Department of Cardiology, Ochsner Clinic Foundation, New Orleans, La, USA
    • Corresponding Author InformationReprint requests: Hector O. Ventura, MD, Ochsner Clinic Foundation, 1514 Jefferson Hwy, New Orleans, LA 70121, USA.
    • ,
  • Mandeep R Mehra, MD

      Affiliations

    • Department of Cardiology, Ochsner Clinic Foundation, New Orleans, La, USA

References 

  1. Hippocrates. The book of prognostics. In: Adams F, editor. The genuine works of Hippocrates, volume I. London: C&J Adlars Printers; 1849. p. 234
  2. Mehra MR, Ventura HO. Heart failure. In:  Civetta JM,  Taylor RW,  Kirby RR editor. Critical care. 3rd ed. Philadelphia: J.B. Lippincott Company; 1997;p. 1887–1903
  3. Hunt S, Baker D, Chin M, et al.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult (a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines). J Am Coll Cardiol. 2001;38:2101–2113
  4. Cowburn P, Cleland J, Coats A, et al.  Risk stratification in chronic heart failure. Eur Heart J. 1998;19:696–710
  5. Mancini D, LeJemtel T, Aaronson K. Peak VO2 (A simple yet enduring standard). Circulation. 2000;101:1080–1082
  6. Milani RV, Mehra MR, Reddy T, et al.  Ventilation/carbon dioxide production ratio in early heart exercise predicts poor functional capacity in congestive heart failure. Heart. 1996;76:393–396
  7. Osman AF, Lavie CJ, Mehra MR, et al.  The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol. 2000;36:2126–2131
  8. Packer M, Fowler MB, Roecker EB, et al.  Effect of carvedilol on the morbidity of patients with sever chronic heart failure (results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study). Circulation. 2002;106:2194–2199
  9. Stevenson L, Steimle A, Fonarow G, et al.  Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995;25:163–170
  10. Florea, Henein M, Anker S, et al. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J 2000;21:146–53
  11. Levine T, Levine A, Goldberg A, et al.  Reversal of end stage heart failure is predicted by long term therapeutic response rather than initial hemodynamic and neurohormonal profile. J Heart Lung Transplant. 1996;15:297–303
  12. Gullestad L, Myers J, Ross H, et al.  Serial exercise testing and prognosis in slected patients considered for heart transplantation. Am Heart J. 1998;135:221–229
  13. Grigioni F, Barbieri A, Magnani G, et al. Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications. Am Heart J 2003; 146: 298–303
  14. Abraham WT, Fisher WG, Smith AL, et al.  Cardiac resynchronization in heart failure. N Engl J Med. 2002;346:1845–1853
  15. Zugck C, Haunstetter A, Kruger C, et al.  Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol. 2002;15:1615–1622
  16. Hippocrates. The book of prognostics. In: Adams F, editor. The genuine works of Hippocrates, volume I. London: C&J Adlars Printers; 1849. p. 18

PII: S0002-8703(03)00234-5

doi: 10.1016/S0002-8703(03)00234-5

American Heart Journal
Volume 146, Issue 2 , Pages 215-217 , August 2003

Article Tools